Effects of hemin on apoptosis, suppression of cytochrome C oxidase gene expression, and bone-marrow toxicity induced by doxorubicin (Adriamycin)

Biochemical Pharmacology

Volumn 52, Issue 5, 1996, Pages 713-722

  Papadopoulou, Lefkothea C ^a   Tsiftsoglou, Asterios S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

adriamycin; apoptosis; cytochrome c oxidase genes; doxorubicin; hemin; human K 562 cells; myelosuppression

Indexed keywords

CYTOCHROME C OXIDASE; DOXORUBICIN; HEMIN; METHOTREXATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW SUPPRESSION; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RNA HYBRIDIZATION;

EID: 0030582452     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00349-8     Document Type: Article

References (36)

1. 1. Chang J, Allen TD and Dexter TM, Long-term bone marrow cultures: Their use in autologous marrow transplantation. Cancer Cells 1: 17-24, 1989.
2. 2. Di Marco A, Adriamycin (NSC-123127): mode and mechanism of action. Cancer Chemother Rep [Part 3] 6: 91-106, 1975.
3. 3. Tritton TR and Yee G, The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science 217: 248-250, 1982.
4. 4. Mimnaugh EG, Kennedy KA, Trush MA and Sinha BK, Adriamycin-enhanced mebrane lipid peroxidation in isolated rat nuclei. Cancer Res 45: 3296-3304, 1985.
5. 5. Doroshow JH, Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res 43: 460-472, 1983.
6. 6. Tewey KM, Rowe TC, Yang L, Halligan BD and Liu LF, Adriamycin induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466-468, 1984.
7. 7. Bachmann E, Weber E and Zbinden G, Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts. Agents Actions 5: 383-393, 1975.
8. 8. Muhammed H, Ramasarma T, Ramakrishna Kurup CK, Inhibition of mitochondrial oxidative phosphorylation by adriamycin. Biochim Biophys Acta 722: 43-50, 1982.
9. 9. Papadopoulou LC and Tsiftsoglou AS, Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue. Cancer Res 53: 1072-1078, 1993.
10. 10. Ling YH, Priebe W and Perez-Soler R, Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852, 1993.
11. 11. Thompson CB, Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
12. 12. Myers CD, Katz FE, Joshi G and Millar JL, A cell line secreting stimulating factors for CFU-GEMM culture. Blood 64:152-155, 1984.
13. 13. Lozzio CB and Lozzio BB, Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321-334, 1975.
14. 14. Zeviani M, Nakagawa M, Herbert J, Lomax MI, Grossman LI, Sherbany AA, Miranda AF, DiMauro S and Schon EA, Isolation of a cDNA clone encoding subunit IV of human cytochrome c oxidase. Gene 55: 205-217, 1987.
15. 15. Mita S, Schmidt B, Schon EA, DiMauro S and Bonilla E, Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Nad Acad Sci USA 86: 9509-9513, 1989.
16. 16. Van Itallie CM and Dannies PS, Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells. Mol Endocrin 2: 332-337, 1988.
17. 17. Davis LG, Dibner MD and Battey JF, Preparation of DNA from eukaryotic cells: General method. In: Basic Methods in Molecular Biology, pp. 44-46. Elsevier Science Publishing Co., Inc., New York, 1986.
18. 18. Gussela JF, Geller R, Clarke B, Weeks V, Housman D, Significance of the cell cycle in commitment of murine erythroleukemia cells: a stochastic analysis. Cell 9: 221-229, 1976.
19. 19. Auffray C and Rougeon F, Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107: 303-314, 1980.
20. 20. Sambrook J, Fritsch EF, Maniatis T, Molecular Cloning, 2nd Ed, Cold Spring Harbor Laboratory Press, 1989.
21. 21. Church GM and Gilbert W, Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995, 1984.
22. 22. Dexter TM, Allen TD and Lajtha LG, Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91: 335-344, 1977.
23. 23. McLeod DL, Shreeve MM and Axelrad AA, Improved plasma culture system for production of erythrocytic colonies in vitro: Quantitative assay method for CFU-E. Blood 44: 517-534, 1974.
24. 24. Steinberg HN, Tsiftsoglou AS and Robinson SH, Loss of suppression of normal bone marrow colony formation by leukemic cell lines after differentiation is induced by chemical agents. Blood 65: 100-106, 1985.
25. 25. Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A and Aglietta M, Opposite effect of Tumor Necrosis Factor α on granulocyte colony stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Cancer Res 50: 5065-5071, 1990.
26. 26. Tsiftsoglou AS, Wong W and Robinson SH, Analysis of hemin-induced protection of human hemopoietic cells from the cytotoxic effects of anthracyclines. Cancer Res 48: 3566-3570, 1988.
27. 27. Tsiftsoglou AS, Wong W, Tsamadou AI and Robinson SH, Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells. Exp. Hematol 19: 928-933, 1991.
28. 28. Tsiftsoglou AS, Wong W, Wheeler C, Steinberg HN and Robinson SH, Prevention of anthracycline-induced cytotoxicity in hemopoietic cells by hemin. Cancer Res 46: 3436-3440, 1986.
29. 29. Monette FC and Holden SA, Hemin enhances the in vitro growth of primitive erythroid progenitor cells. Blood 60: 527-530, 1982.
30. 30. Monette FC, Holden SA, Sheehy MJ and Matzinger EA, Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation. Exp. Hematol 12: 782-787, 1984.
31. 31. Kaye FJ, Weinberg RS, Schofield JM and Alter BP, The effect of hemin in vitro and in vivo on human erythroid progenitor cells. Int J Cell Cloning 4: 432-446, 1986.
32. 32. Chertkov JL, Jiang S, Lutton JD, Levere RD and Abraham NG, Hemin stimulation of hemopoiesis in murine long-term bone marrow culture. Exp Hematol 19: 905-909, 1991.
33. 33. Abraham NG, Heme regulation of hematopoietic stem cell growth and development. In: Concise Reviews in Clinical and Experimental Hematology, (Ed. Murphy MJ.Jr) pp. 357-373, AlphaMed Press, Dayton, OH, 1992.
34. 34. Abraham NG, Cherkov JL, Staudinger R, Jiang S, Lutton JD, Argani I. Levere RD and Kappas A, Long-term bone marrow stromal and hemopoietic toxicity to AZT: Protective role of heme and IL-1. Exp Hematol 21: 263-268, 1993.
35. 35. Papadopoulou LC, Wheeler C and Tsiftsoglou AS, Possible role of mitochondrial components in adriamycin-induced cytotoxicity of human leukemia cells. J Chemotherapy [Suppl 4] 1: 1151-1154, 1989.
36. 36. Wheeler C, Robinson SH, Tsiftsoglou AS, Interactions of daunomycin (DN) with heme and hemoproteins: implications for the mode of action of anthracycline drugs. Blood [Suppl 1] 64: 177a, 1984.